ABOUT THE 2018 FH GLOBAL SUMMIT
The FH Global Summit is the only conference dedicated to solving global challenges in the care and treatment of familial hypercholesterolemia (FH) through a multi-stakeholder and interdisciplinary approach. An invitation-only event, the summit features a stellar lineup of speakers and panelists who are experts in FH, genomics, precision medicine, alongside leading healthcare practitioners, individuals with FH and industry.
The 2018 FH Global Summit will focus on implementation science and developing methods to accelerate the uptake of research into clinical practice and health policy. We will commemorate the 20-year anniversary of the World Health Organization recommendations on FH and collectively develop solutions to stop premature heart disease and death by making early diagnosis and treatment of FH a reality.
Each year, the FH Global Summit serves as a catalyst to new solutions and thinking that have led to multiple innovations in FH care. Join us to become part of the change.
The Summit was fantastic, the most exciting meeting that I have participated in regarding familial hypercholesterolemia. From the scientific content to the networking activity, all the details were perfect.
Pablo Corral, MD Instituto Clínica Médica, Argentina
It’s amazing to see how many doctors are doing research around the world to help with our condition. It was a once in a lifetime opportunity to be able to meet world-renowned FH experts and tell them my story.
Jen Farnell FH Advocate for Awareness
This has truly been a fantastic meeting. The FH Foundation has done a fantastic job in highlighting the gaps in understanding, rate of diagnosis and care, and making sure that we are aware of the challenges and the lives we are saving.
George Mensah, MD, FACC
National Heart, Lung, and Blood Institute
During the 2017 FH Global Summit, leaders from the National Heart Lung and Blood Institute to the World Heart Federation led critical discussions about the importance of phenotypes to genotypes, to optimizing care across diverse populations, to opportunities in precision medicine and public health. Dr. Kastelein set forth the historical and current efforts made to address detection and treatment of individuals with FH while reminding us all of the future progress required. The FH Foundation presented Dr. Nanette K. Wenger with the FH Pioneer award for her extraordinary leadership in academic and clinical medicine that redefined how the medical community perceives cardiovascular disease.